pravastatin has been researched along with dasatinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bathena, S; Chang, M; Christopher, LJ; Roy, A; Shen, H | 1 |
1 review(s) available for pravastatin and dasatinib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for pravastatin and dasatinib
| Article | Year |
|---|---|
Prediction of drug-drug interaction potential mediated by transporters between dasatinib and metformin, pravastatin, and rosuvastatin using physiologically based pharmacokinetic modeling.
Topics: Dasatinib; Drug Interactions; Humans; Liver-Specific Organic Anion Transporter 1; Metformin; Models, Biological; Pravastatin; Rosuvastatin Calcium; Solute Carrier Organic Anion Transporter Family Member 1B3 | 2022 |